Author(s):
Aakanksha C. Kumbhar, Prerana B. Gherade, Sandhyarani S. Sonkamble, Kumudini R. Pawar
Email(s):
aakankshakumbhar01@gmail.com
DOI:
10.52711/2231-5675.2024.00050 
Address:
Aakanksha C. Kumbhar, Prerana B. Gherade, Sandhyarani S. Sonkamble, Kumudini R. Pawar
Department of Pharmaceutical Quality Assurance, Abhinav College of Pharmacy, Narhe, Pune, 411041.
*Corresponding Author
Published In:
Volume - 14,
Issue - 4,
Year - 2024
ABSTRACT:
Ritonavir, a potent antiretroviral agent, plays a crucial role in the management of human immunodeficiency virus (HIV) infections. As its therapeutic importance grows, the need for accurate and reliable analytical methods to assess the quality and purity of ritonavir becomes paramount. This review aims to provide a comprehensive overview of the various analytical techniques employed for the quantification, identification, and characterization of ritonavir in pharmaceutical formulations. This review aims to assist researchers, pharmaceutical professionals, and regulatory authorities in selecting the most appropriate analytical methods for ritonavir analysis.
Cite this article:
Aakanksha C. Kumbhar, Prerana B. Gherade, Sandhyarani S. Sonkamble, Kumudini R. Pawar. A Comprehensive Review of Analytical Methods of Ritonavir. Asian Journal of Pharmaceutical Analysis. 2024; 14(4):283-2. doi: 10.52711/2231-5675.2024.00050
Cite(Electronic):
Aakanksha C. Kumbhar, Prerana B. Gherade, Sandhyarani S. Sonkamble, Kumudini R. Pawar. A Comprehensive Review of Analytical Methods of Ritonavir. Asian Journal of Pharmaceutical Analysis. 2024; 14(4):283-2. doi: 10.52711/2231-5675.2024.00050 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2024-14-4-14
REFERENCES:
1. Talha, B., Dhamoon, A.S. Ritonavir. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK544312/
2. Eckhardt, B. J., Gulick, R. M. Drugs for HIV Infection. Infectious Diseases. 2017; 1293–1308.e2.
3. Tsibris, A. M. N., and Hirsch, M. S. (2015). Antiretroviral Therapy for Human Immunodeficiency Virus Infection. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 1622–1641.e6. doi:10.1016/b978-1-4557-4801-3.00130-2
4. National Center for Biotechnology Information. PubChem Compound Summary for CID 392622, Ritonavir. Retrieved December 15, 2023 from https://pubchem.ncbi.nlm.nih.gov/compound/Ritonavir.
5. Ritonavir. (2023, December 12). Wikipedia. https://en.wikipedia.org/wiki/Ritonavir
6. Ritonavir. Retrieved December 15, 2023, from https://go.drugbank.com/drugs/DB00503
7. Oncall, P. Ritonavir. Pediatriconcall.com. Retrieved December 15, 2023.
8. Abdu Hussen, A. High-Performance Liquid Chromatography (HPLC): A review. Annals of Advances in Chemistry. 2022; 6(1): 10–20. https://doi.org/10.29328/journal.aac.1001026
9. Prakash Babar, R., Khatmode, R. B., Shivanjali, M., Mane, S., Giri, T., and Pharm, M. (n.d.). Performance liquid chromatography technique. IJCRT.org. Retrieved December 15, 2023, from https://ijcrt.org/papers/IJCRT2205570.pdf
10. Attimarad, M., Mueen Ahmed, K. K., Aldhubaib, B. E., and Harsha, S. High-performance thin layer chromatography: A powerful analytical technique in pharmaceutical drug discovery. Pharmaceutical Methods. 2011; 2(2): 71–75.
11. Rashmin, P., Mrunali, P., Nitin, D., Nidhi, D., and Bharat, P. (n.d.). HPTLC method development and validation: Strategy to minimize HPTLC method development and validation: Strategy to minimize methodological failures methodological failures.
12. Pradip, P. S., and Krunal, K. Bioanalytical method development and validation: A review. Humanjournals.com. Retrieved December 15, 2023, from https://ijppr.humanjournals.com/wp-content/uploads/2023/05/27.Pawal-Suvarna-Pradip-Kanase-Krunal.pdf.
13. Noriega, P., Gortaire, G., and Osorio, E. Mass spectrometry and its importance for the analysis and discovery of active molecules in natural products. In Natural Drugs from Plants. IntechOpen. 2022
14. Meghal Patel. Development and Validation of Simultaneous Estimation of Two Catecholamines in Combine Dosage Form by HPTLC Method. Asian J. Pharm. Ana. 2014; 4(2): 57-77
15. V. Jain, Tripti Jain, Swarnlata Saraf, S. Saraf. HPTLC method for routine quality control of Ayurvedic formulation Drakshadigutika. Asian J. Pharm. Ana. 2013; 3(4): 111-114
16. Bhole, R. P., Jagtap, S. R., Chadar, K. B., andZambare, Y. B. Liquid chromatography-mass spectrometry technique-A review. Research Journal of Pharmacy and Technology. 2020; 13(1): 505. https://doi.org/10.5958/0974-360x.2020.00097.9
17. Thakur, P., Thakur, U., Kaushal, P., Ankalgi, A. D., Kumar, P., Kapoor, A., and Singh Ashawat, M. A review on GC-MS hyphenated technique. Asian Journal of Pharmaceutical Analysis. 2021: 285–292. https://doi.org/10.52711/2231-5675.2021.00049
18. Schönberger, T., Bachmann, R., Gerhardt, N., Panzer, J., Meyer, K., Romoth, M., Teipel, J., Scharinger, A., Weber, M., Kuballa, T., Maiwald, M., Esslinger, S., Fauhl-Hassek, C., Horn, B., Riedl, J., Becker, R., Annweiler, E., Meier, M., Ohmenhäuser, M., Stoyke, M. (2023). Guide to NMR method development and validation – part I: Identification and quantification (update 2023).
19. Wikipedia contributors. (2023, November 19). Fourier-transform infrared spectroscopy. Wikipedia, The Free Encyclopedia. https://en.wikipedia.org/w/index.php?title=Fourier-transform_infrared_spectroscopyandoldid=1185833387
20. Fahelelbom, K. M., Saleh, A., Al-Tabakha, M. M. A., andAshames, A. A. Recent applications of quantitative analytical FTIR spectroscopy in pharmaceutical, biomedical, and clinical fields. Reviews in Analytical Chemistry. 2022; 41(1): 21–33.
21. Devineni, Jyothirmayee and Vasumathi, Ranganiand Sravya, Nunna. New sensitive uv spectrophotometric method for simultaneous estimation of lopinavir and ritonavir in fixed dose combination as soft gels. International Journal of Pharmaceutical Development and Technology. 2017.
22. Dias, C. L., Bergold, A. M., andFröehlich, P. E. UV-derivative spectrophotometric determination of ritonavir capsules and comparison with LC method. Analytical Letters. 2009; 42(12): 1900–1910. https://doi.org/10.1080/00032710903060701
23. Salunke, J. M., Pawar, D. S., Chavhan, V. D., andGhante, M. R. Simultaneous UV spectrophotometric method for estimation of ritonavir and lopinavir in bulk and tablet dosage form. Scholarsresearchlibrary.com. 2013
24. Siddiqui, M. R., AlOthman, Z. A., and Rahman, N. Analytical techniques in pharmaceutical analysis: A review. Arabian Journal of Chemistry. 2017; 10: S1409–S1421. https://doi.org/10.1016/j.arabjc.2013.04.016
25. P. Shinde, K., and D. Rajmane, A. (2023). A review UV method development and validation. Asian Journal of Pharmaceutical Analysis, 122–130. https://doi.org/10.52711/2231-5675.2023.00021
26. S. Selvakumar, S. Ravichandran, L. Matsyagiri. Development and Validation of analytical method for Simultaneous estimation of Ornidazole and Cefixime trihydrate tablet dosage forms by UV spectroscopy. Asian J. Pharm. Ana. 2016; 6(4): 246-252
27. Verma, G., and Mishra, M. Development and optimization of UV-Vis Spectroscopy -a review.
28. Bhavyasri, D. K., Sreshta, M., and Sumakanth, D. M. Simultaneous method development, validation and stress studies of darunavir and ritonavir in bulk and combined dosage form using UV spectroscopy. Scholars Academic Journal of Pharmacy., 2020; 9(8): 244–252. https://doi.org/10.36347/sajp.2020.v09i08.003
29. Peerzade, M. Y., Memon, S., Bhise, K., and Aamer, A. I. Development and validation of UV-Visible spectrophotometric method for estimation of ritonavir in bulk and formulation. Thepharmajournal.com. Retrieved December 17, 2023, from
30. Chiranjeevi, K., Channabasavaraj, K. P., Srinivas Reddy, P., and Nagaraju, P. T. Development and validation of spectrophotometric method for quantitative estimation of ritonavir in bulk and pharmaceutical dosage forms. Sphinxsai.com. Retrieved December 17, 2023, from https://sphinxsai.com/Vol.3No.1/chem_jan-mar11/pdf/CT=10(58-62)%20JMCT11.pdf
31. Jadhav, S. R., Alhat, H. P., and Joshi, S. Analytical methods development and validation for simultaneous estimation of lopinavir and ritonavir in pharmaceutical formulation by simultaneous equation method using UV spectrophotometry. International Research Journal of Pharmacy. 2018; 9(8): 57–62. https://doi.org/10.7897/2230-8407.098165
32. K. Vijaya Sri, S. Deepthi, M. Madhuri, P. V. Aishwarya. Development and Validation of UV Spectroscopic by Q-absorption Ratio, RP-HPLC Method for Simultaneous Estimation of Atazanvir and Ritonavir in bulk and Pharmaceutical Dosage Form. Asian J. Pharm. Ana. 2019; 9(3): 138-150
33. Seetaramaiah, K., Anton Smith, A., Ramyateja, K., Alagumanivasagam, G., and Manavalan, R. Spectrophotometric determination of ritonavir in bulk and pharmaceutical formulation. Tsijournals.com. Retrieved December 17, 2023.
34. Bhavyasri, K., Sindhu, K., and Rambabu, D. Method development, validation and forced degradation studies of ritonavir, an Retroviral drug using UV-visible spectroscopy. Journal of the Gujarat Research Society. 2019; 21(1): 55–60.
35. Poornima, B., Jayachandra Reddy, P., and Neelima, D. S. S. Method development and validation for the simultaneous determination of Ritonavir and Lopinavir by RP-HPLC and by UV- Spectrophotometry. IJPAR Journal. 2019; 8(2): 227–240.
36. Sri, K. V., Deepthi, S., Madhuri, M., and Aishwarya, P. V. Development and validation of UV spectroscopic by Q-absorption ratio, RP-HPLC method for simultaneous estimation of atazanvir and ritonavir in bulk and pharmaceutical dosage form. Asian Journal of Pharmaceutical Analysis. 2019; 9(3): 138. https://doi.org/10.5958/2231-5675.2019.00026.7
37. Akbel, E. Analytical methods for the quantification of ritonavir in pharmaceuticals, a comparative evaluation. Bulletin of the Chemical Society of Ethiopia. 2022; 36(4): 737–747. https://doi.org/10.4314/bcse.v36i4.2
38. Rohini S. Koli, Aslam S. Patel, Kamlesh N. Chaudhari, Khushbu R. Patil. A Review on HPLC and Its New Trends. Asian J. Pharm. Ana. 2018; 8(4): 233-236
39. Parveen, N., Routh, T., Goswami, A. K., and Mondal, S. A new robust analytical method development, validation, and stress degradation studies for estimating ritonavir by UV-spectroscopy and hplc methods. International Journal of Applied Pharmaceutics. 2023; 214–224. https://doi.org/10.22159/ijap.2023v15i4.47924
40. Behera, A., Moitra, S., Si, S., Meher, A., and Sankar, A. G. Method development, validation and stability study of ritonavir in bulk and pharmaceutical dosage form by spectrophotometric method. Chronicles of Young Scientists. 2011; 2(3): 161.
41. Rao, L., Neelima, K., and Likitha, S. P. Development and validation of new analytical methods for the estimation of ritonavir in bulk and pharmaceutical dosage forms. International Journal of Pharma Research and Health Sciences.
42. Trivedi CD, Mardia RB, Suhagia BN and Chauhan SP. Development and validation of spectrophotometric method for the estimation of Ritonavir in tablet dosage form. Int J Pharm Sci Res 2013; 4(12): 4567-72. doi: 10.13040/IJPSR. 0975- 8232.4(12).4567-72
43. Wjpps. (n.d.). Wjpps.com. Retrieved December 17, 2023, from https://www.wjpps.com/wjpps_controller/abstract_id/5650
44. Dinakaran, S. K., Botla, D. N. P., Pothula, A., Kassetti, K., Avasarala, H., and Kakaraparthy, R. Spectrophotometric method development and validation for valacyclovir hydrochloride monohydrate and ritonavir in bulk and tablet dosage form using absorption ratio method. Usm.My. Retrieved December 17, 2023.
45. Lopinavir, E. O. F., and RP-HPLC, R. B. Y. Analytical method development and validation for simultaneous. Omicsonline.org. Retrieved December 17, 2023, from https://www.omicsonline.org/open-access-pdfs/analytical-method-development-and-validation-for-simultaneous-estimation-of-lopinavir-and-ritonavir-by-rphplc-.pdf
46. Pallavi, S., and Sowjanya, G. Development and validation of a new RP-UPLC method for the simultaneous estimation of nirmatrelvir and ritonavir in bulk and copacked tablet dosage forms. Research Journal of Pharmacy and Technology. 2023; 4370–4376. https://doi.org/10.52711/0974-360x.2023.00715
47. Baje, S. I., Jyothi, B., and Madhavi, N. RP-HPLCmethod for simultaneous estimation of ritonavir, ombitasvir and paritaprevir in tablet dosage forms and their stress degradation studies. International Journal of Applied Pharmaceutics. 2019; 193–210. doi:10.22159/ijap.2019v11i2.28141
48. Hamid Khan, Javed Ali. UHPLC: Applications in Pharmaceutical Analysis. Asian J. Pharm. Ana. 2017; 7(2): 124-131
49. Musuluri, Murali. (2011). A RP-HPLC method for the estimation of Ritonavir in pharmaceutical dosage forms. Journal of Pharmacy Research. 2011; 4: 3049.
50. Nagaraju, P. T., Chinna, G. P., Venugopal, N., Ravindranath, S., Bhanu, P. B., and Sade, S. (n.d.). Reverse phase hplc method for determination of ritonavir in pharmaceutical preparations. Globalresearchonline.net. Retrieved December 17, 2023, from https://globalresearchonline.net/journalcontents/v13-2/012.pdf
51. Menda, J., Kanuparthy, P. R., Katari, N. K., Kowtharapu, L. P., Ettaboina, S. K., and Pydimarry, S. P. R. Quality by design tool–evaluated stability‐indicating ultra‐performance liquid chromatography method for the determination of drugs (ritonavir and darunavir) used to treat the human immunodeficiency virus/acquired immunodeficiency syndrome. Biomedical Chromatography: BMC. 2023; 37(9): https://doi.org/10.1002/bmc.5687
52. Imam, M.S., Batubara, A.S., Gamal, M. et al. Adjusted green HPLC determination of nirmatrelvir and ritonavir in the new FDA approved co-packaged pharmaceutical dosage using supported computational calculations. Sci Rep. 2023; 13: 137 https://doi.org/10.1038/s41598-022-26944-y
53. Gandhi, S. K., and Mandal, B. K. Development and Validation of RP-HPLC Method for the simultaneous determination of Nirmatrelvir and Ritonavir in bulk and pharmaceutical formulation. Research Journal of Chemistry and Environment. 2023; 27(4): 120–127. https://doi.org/10.25303/2704rjce1200127
54. Suresh Babu, A. V., Sharma, H. K., Venkata, A., and Babu, S. (n.d.). Method development and validation of ritonavir and nirmatrelvir in tablet dosage form by using RP-High Performance Liquid Chromatography. https://doi.org/10.31838/ecb/2023.12.si1.0100
55. Maneka, S. L., R. T. Saravanakumar, and A. Male. “Stability-Indicating Method Development and Validation for Simultaneous Estimation of Ombitasvir, Paritaprevir, and Ritonavir in Formulation by Ultra Performance Liquid Chromatography”. International Journal of Pharmaceutical Sciences and Drug Research. 2020; 12(5): 457-63, doi:10.25004/IJPSDR.2020.120505.
56. Jitta, S. R., Bhaskaran, N. A., Kumar, L., and Shirodkar, R. K. Development and validation of RP-HPLC method for quantification of total, free and entrapped ritonavir in lipid nanocarriers and drug content of film coated fixed dose formulation. Indian Journal of Pharmaceutical Education. 2022; 56(3s): s547–s558. https://doi.org/10.5530/ijper.56.3s.164
57. Rani J, D. B., and Deepti, A. (). Development of a simple accurate method, validation and it’s degradation studies of nirmatrelvir, ritonavir in bulk and marketed formulation by RP-HPLC. International Journal of Pharmaceutical Quality Assurance. 2023; 14(3): 740–744. https://doi.org/10.25258/ijpqa.14.3.47
58. Dagadeeswaran, and Gopal. Quantitative estimation of lopinavir and ritonavir in tablets by RP-HPLC method. Pharmaceutica Analytica Acta. 2012; 3(5). https://doi.org/10.4172/2153-2435.1000160
59. Killi, G. D., Maddinapudi, R. K., Dinakaran, S. K., and Harani, A. A novel validated UPLC method for quantitation of lopinavir and ritonavir in bulk drug and pharmaceutical formulation with its impurities. Brazilian Journal of Pharmaceutical Sciences. 2014; 50(2): 301–308. https://doi.org/10.1590/s1984-82502014000200009
60. Arun, R., and Anton Smith, A. Development and validation of analytical method for lopinavir and ritonavir by HPLC. International Journal of Drug Development and Research, 2013; 5(2). https://www.itmedicalteam.pl/articles/development-and-validation-of-analytical-method-for-lopinavir-and-ritonavir-by-hplc-100845.html
61. Rane, S. S., and and, R. Y. C. Method development and validation of RP hplc method for estimation of antiviral combination as atazanavir and ritonavir in bulk and pharmaceutical dosage form. Ijcrt.org. Retrieved December 18, 2023, from https://ijcrt.org/papers/IJCRT2204034.pdf
62. Al-Zoman, N. Z., Maher, H. M., and Al-Subaie, A. Simultaneous determination of newly developed antiviral agents in pharmaceutical formulations by HPLC-DAD. Chemistry Central Journal. 2017; 11(1). https://doi.org/10.1186/s13065-016-0232-6
63. Raju, P., K. Thejomoorthy, andP. Sreenivasa Prasanna. Development and validation of new analytical method for the simultaneous estimation of Darunavir and Ritonavir in pharmaceutical dosage form. International Journal of Indigenous Herbs and Drugs. 2021; 49–57. https://doi.org/10.46956/ijihd.vi.157
64. Ponnilavarasan, I., Rajasekaran, A., Dharuman, J. G., Kalaiyarasi, D., and Senthilkumar, M. RP – HPLC method for simultaneous estimation of antiretroviral drugs dosage form. Chalcogen.Ro. Retrieved December 20, 2023, from https://www.chalcogen.ro/771_Ponilvarasan1.pdf
65. Sravan, G., Reddy, K., Ashutosh Kumar, S., and Kumar, R. (n.d.). An analytical method development and validation for simultaneous estimation of atazanavir and ritonavir in tablet dosage forms by using UPLC. Rjpbcs.com. Retrieved December 20, 2023, from https://www.rjpbcs.com/pdf/2014_5(6)/ [187].pdf
66. Prathap, B., Haribaskar, V., Kumar, B., Harika, S., Kavitha, M., and Bhavya, C. (n.d.). Stability indicating RP-hplc method for simultaneous estimation of Ritonavir and Darunavir in bulk and its Synthetic Mixture. Jgtps.com. Retrieved December 20, 2023, from https://www.jgtps.com/admin/uploads/48QfWp.pdf
67. Chinnaiah P, Lanka AR, Pamidi S, Govada PPR. A new uplc method for the separation and quantitation of process and degradation related impurities in the combined dosage tablets of darunavir and ritonavir. J Compr Phar 2015;2(3):84-97.
68. Varaprasad, C., and Ramakrishna, K. (2015). Simultaneous quantification of atazanavir and ritonavir in pharmaceutical dosage form by validated RP-HPLC method. Humanjournals.com. https://ijppr.humanjournals.com/wp-content/uploads/2015/07/2.C.Varaprasad-and-K.Ramakrishna1.pdf
69. Martens-Lobenhoffer, J., Böger, C. R., Kielstein, J., and Bode-Böger, S. M. (2022). Simultaneous quantification of nirmatrelvir and ritonavir by LC-MS/MS in patients treated for COVID-19. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 1212(123510), 123510. https://doi.org/10.1016/j.jchromb.2022.123510
70. Koppala, S., Panigrahi, B., Raju, S. V. N., Padmaja Reddy, K., Ranga Reddy, V., and Anireddy, J. S. (2015). Development and validation of a simple, sensitive, selective and stability-indicating RP-UPLC method for the quantitative determination of ritonavir and its related compounds. Journal of Chromatographic Science, 53(5), 662–675. https://doi.org/10.1093/chromsci/bmu097
71. Rao, R. N., Ramachandra, B., Vali, R. M., and Raju, S. S. (2010). LC–MS/MS studies of ritonavir and its forced degradation products. Journal of Pharmaceutical and Biomedical Analysis, 53(4), 833–842. https://doi.org/10.1016/j.jpba.2010.06.004
72. Venugopal, N., Vijaya Bhaskar Reddy, A., and Madhavi, G. (2014). Development and validation of a systematic UPLC–MS/MS method for simultaneous determination of three phenol impurities in ritonavir. Journal of Pharmaceutical and Biomedical Analysis, 90, 127–133. https://doi.org/10.1016/j.jpba.2013.11.029
73. Mishra, T., and Shrivastav, P. S. (2014). Validation of simultaneous quantitative method of HIV protease inhibitors atazanavir, darunavir and ritonavir in human plasma by UPLC-MS/MS. TheScientificWorldJournal, 2014, 1–12. https://doi.org/10.1155/2014/482693
74. Hernández-Pineda, J., Jung-Cook, H. H., Katende-Kyenda, N. L., Galindo-Sevilla, N., Domínguez-Castro, M., Romo-Yañéz, J., Ramírez-Ramírez, A., Irles, C., and Figueroa-Damián, R. (2020). Assessment of lamivudine, zidovudine, lopinavir, and ritonavir plasma levels in HIV-positive pregnant women: Drug monitoring application to improve patient safety. Medicine, 99(22), e20487. https://doi.org/10.1097/md.0000000000020487
75. Rao, R. N., Ramachandra, B., Vali, R. M., and Raju, S. S. (2010). LC–MS/MS studies of ritonavir and its forced degradation products. Journal of Pharmaceutical and Biomedical Analysis, 53(4), 833–842. https://doi.org/10.1016/j.jpba.2010.06.004
76. Sulebhavikar, A. V., Pawar, U. D., Mangoankar, K. V., and Prabhu-Navelkar, N. D. (n.d.). HPTLC method for simultaneous determination of lopinavir and ritonavir in capsule dosage form. Hindawi.com. Retrieved December 23, 2023, from https://downloads.hindawi.com/journals/chem/2008/539849.pdf
77. Dr.G. Dharmamoorthy, S. Roopanvitha, K. Harshitha, Y. Krupananda, A. Tharunkumar5, Dr. Mallikarjuna B. P, and Dr.M. Pradeep. (2023). Stability indicating hptlc method for estimation of lopinavir and ritonavir in fixed-dose combination tablets. Journal of Population Therapeutics and Clinical Pharmacology, 30(15), 527–540. https://doi.org/10.53555/jptcp.v30i15.2563
78. Patel, D. J., Desai, S. D., Savaliya, R. P., and Gohil, D. Y. (n.d.). Simultaneous hptlc determination of lopinavir and ritonavir in combined dosage form. Innovareacademics.In. Retrieved December 24, 2023, from https://innovareacademics.in/journal/ajpcr/Vol4Issue1/154.pdf
79. Vanita P. Rode, Madhukar R. Tajne. A Validated Stability-Indicating High-Performance Thin-Layer Chromatographic Method for the Analysis of Pitavastatin in Bulk Drug and Tablet Fomulation. Asian J. Pharm. Ana. 2018; 8(1): 49-52
80. Suhagia, Dr and Patwari, Arpit and K.A., Patel and Dabhi, and H, Desai and Ezhava, Sindhu and I.S., Rathod. (2012). Simultaneous Determination of Ritonavir and Lopinavir in Combined Tablet Dosage Form.by HPTLC Method. Journal of Pharmaceutical and Bioanalytical Science. 1. 56-61.
81. Vaishali C. Kulkarni, Manisha D. Khemnar, Amruta C. Menkudale, Dr. Rupesh J. Patil, Dr. Kishor V. Otari. Hydrotropy: A Boon in Thin layer Chromatography A Review. Asian J. Pharm. Ana. 2020; 10(1):40-43
82. Mardia, R. B., Suhagia, B. N., Pasha, T. Y., Chauhan, S. P., and Solanki, S. D. (2012). Development and validation of HPTLC method for simultaneous analysis of lopinavir and ritonavir in their combined tablet dosage form. International Journal for Pharmaceutical Research Scholars, 1(1), 39–44. https://doi.org/10.31638/ijprs.v1.i1.00017
83. Shinde Ganesh S., P. S. Rao, R. S. Jadhav, PiyushaKolhe, Diksha Athare. A Review on Chromatography and Advancement in Paper Chromatography Technique. Asian J. Pharm. Ana. 2021; 11(1):45-48
84. Nachiket V. Rajput, Manvir V. Rajput, Vikas V. Patil, Pankaj S. Patil, Amol R. Pawar. Short Review on Comparative Study of Chromatography. Asian Journal of Pharmaceutical Analysis. 2023; 13(1):53-8
85. Saraya, R. E., Deeb, S. E., Salman, B. I., and Ibrahim, A. E. (2022). Highly sensitive high‐performance thin‐layer chromatography method for the simultaneous determination of molnupiravir, favipiravir, and ritonavir in pure forms and pharmaceutical formulations. Journal of Separation Science, 45(14), 2582–2590. https://doi.org/10.1002/jssc.202200178
86. Behera, A., Sethy, K., Sankar, D. G., Moitra, S. K., and Si, S. C. (2012). Statistical correlation and simultaneous estimation of atazanavir sulfate and ritonavir in fixed dosage form by high performance liquid chromatography and high-performance thin layer chromatography. Journal of Liquid Chromatography and Related Technologies, 35(12), 1731–1749. https://doi.org/10.1080/10826076.2011.621774
87. Pallavi Mangesh Patil, Sagar Baliram Wankhede, Praveen Digambar Chaudhari. (n.d.). Stability-indicating hptlc method for simultaneous determination of lopinavir and ritonavir in bulk and pharmaceutical dosage form. World journal of pharmacy and pharmaceutical sciences, 3(6), 1613–1629.
88. Patil, P., Wankhede, S. B., and Chaudhari, P. (2016). Separation, identification and characterisation of acidic degradation of ritonavir under ICH recommended stress condition by HPTLC, MS/TOF. Analytical Chemistry Letters, 6(3), 257–271. https://doi.org/10.1080/22297928.2016.1196607
89. S. H. Alhat, H. P. Alhat, S. V. Joshi. (2021). Validated hptlc method for simultaneous determination of lopinavir and ritonavir in tablet dosage form. European journal of pharmaceutical and medical research, 8(3).
90. Abdelhay, M. H., Gazy, A. A., Shaalan, R. A., and Ashour, H. K. (n.d.). Validated stability indicating HPLC and HPTLC methods for the determination of ritonavir in bulk powder and in capsules. https://doi.org/10.6227/jfda.2012200428
91. Induri, M., Mantripragada, B. R., and Yejella, R. P. (n.d.). Simultaneous estimation of atazanavir and ritonavir in tablet dosage form by hptlc method. Pharmascholars.com. Retrieved December 24, 2023, from
92. Priyanka M. Sagar, S.D. Mankar, S. B. Dighe. An Overview on Analytical Method Development and Validation for Ertugliflozin in Bulk and Pharmaceutical Dosage form. Asian Journal of Pharmaceutical Analysis. 2023; 13(3):222-8